Feasibility of multimodal therapy for rhabdomyosarcoma in a patient with Fukuyama congenital muscular dystrophy.

Autor: Sugiyama M; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Arakawa A; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan., Iwata S; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan., Tao K; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Shirakawa N; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Watanabe Y; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Nakajima M; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan., Yoshida A; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Ishigaki K; Department of Pediatrics, Tokyo Women's Medical University School of Medicine, Tokyo, Japan., Kawai A; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan., Ogawa C; Department of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.; Rare Cancer Center, National Cancer Center Hospital, Tokyo, Japan.
Jazyk: angličtina
Zdroj: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Jul; Vol. 71 (7), pp. e31036. Date of Electronic Publication: 2024 Apr 28.
DOI: 10.1002/pbc.31036
Databáze: MEDLINE
Externí odkaz: